"I've a 3 year old daughter who I want to see settled in school. Possibly facing the next line of treatment without Enhertu is terrifying." - Hannah
Enhertu has been provisionally rejected for use on the NHS in England for certain patients with HER2-low secondary breast cancer.
We are interested in discovering better ways to improve workability in women with secondary breast cancer. This new online study investigates what factors affect our workability. Please can you help us? please RT! 🙏#secondarybreastcancer#metastaticbreastcancer@abcdiagnosis
You might work in the health care system, but do you know what the individual costs are of things like an A&E visit or a trip in an ambulance? Our teams have crunched the numbers on the #NHS and pulled them together in this facts and figures piece. https://t.co/eK4lY50wVr
What a turnout at Royal Sussex County Hospital, @UHSussex!
Brilliant to see so many of you join the picket line and fight for the the pay you deserve and the future of the profession.
Amazing to hear so much support from the public 🚗
#FairPayForNursing#RCNStrike